
GC35576
CADD522
Also known as 3-[(3,4-dichlorophenyl)carbamoyl]bicyclo[2.2.1]hept-5-ene-2-carboxylic acid
CADD522 is a RUNX2-DNA binding inhibitor (downregulates RUNX2-mediated transcription of downstream target genes), with an IC50 of 10 nM· CADD522 inhibits primary tumor growth and experimental metastasis of tumor cells in the lungs of immune-compromised mice· CADD522 can be used in study of cancer
ChemicalCAS199735-88-1MW326.17FormulaC15H13Cl2NO3
- CAS number
- 199735-88-1
- Molecular weight
- 326.17
- Formula
- C15H13Cl2NO3
- Solubility
- DMSO: 250 mg/mL (766·47 mM)
- InChIKey
- YSDNWNOGHQYWPK-UHFFFAOYSA-N
- Catalogue number
- GC35576
- Brand
- GLPBIO
Computed properties PubChem CID 2834870 · XLogP 2.9 · TPSA 66.4 Ų · H-bond donors 2
- XLogP
- 2.9
- TPSA
- 66.4 Ų
- H-bond donors
- 2
- H-bond acceptors
- 3
- Rotatable bonds
- 3
- Heavy atoms
- 21
SMILES C1C2C=CC1C(C2C(=O)NC3=CC(=C(C=C3)Cl)Cl)C(=O)O
Computed descriptors from PubChem (CID 2834870), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il